Procedia in Vaccinology

1

The International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: introduction and summary

Stokes, William S, Kulpa-Eddy, Jodie, McFarland, Richard

Journal:

Year:

2011

Language:

english

File:

PDF, 387 KB

english, 2011

2

Non-animal replacement methods for human vaccine potency testing: state of the science and future directions

McFarland, Richard, Verthelyi, Daniela, Casey, Warren, Arciniega, Juan, Isbrucker, Richard, Schmitt, Michael, Finn, Theresa, Descamps, Johan, Horiuchi, Yoshinobu, Sesardic, Dorothea, Stickings, Paul,

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 386 KB

english, 2011

3

Improving animal welfare and reducing animal use for human vaccine potency testing: state of the science and future directions

Casey, Warren, Schmitt, Michael, McFarland, Richard, Isbrucker, Richard, Levis, Robin, Arciniega, Juan, Descamps, Johan, Finn, Theresa, Hendriksen, Coenraad, Horiuchi, Yoshinobu, Keller, James, Kojima

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 368 KB

english, 2011

4

Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions

Isbrucker, Richard, Levis, Robin, Casey, Warren, McFarland, Richard, Schmitt, Michael, Arciniega, Juan, Descamps, Johan, Finn, Theresa, Hendriksen, Coenraad, Horiuchi, Yoshinobu, Keller, James, Kojima

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 449 KB

english, 2011

5

Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions

Kulpa-Eddy, Jodie, Srinivas, Geetha, Halder, Marlies, Hill, Richard, Brown, Karen, Roth, James, Draayer, Hans, Galvin, Jeffrey, Claassen, Ivo, Gifford, Glen, Woodland, Ralph, Doelling, Vivian, Jones,

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 456 KB

english, 2011

6

Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions

Stokes, William S, Brown, Karen, Kulpa-Eddy, Jodie, Srinivas, Geetha, Halder, Marlies, Draayer, Hans, Galvin, Jeffrey, Claassen, Ivo, Gifford, Glen, Woodland, Ralph, Doelling, Vivian, Jones, Brett

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 444 KB

english, 2011

7

Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions

Kulpa-Eddy, Jodie, Srinivas, Geetha, Halder, Marlies, Brown, Karen, Draayer, Hans, Galvin, Jeffrey, Claassen, Ivo, Gifford, Glen, Woodland, Ralph, Doelling, Vivian, Jones, Brett, Stokes, William S

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 446 KB

english, 2011

8

Veterinary Vaccines and Their Importance to Animal Health and Public Health

Roth, James A

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 671 KB

english, 2011

9

U.S. FDA requirements for Human Vaccine Product Safety and Potency Testing

Finn, Theresa M

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 337 KB

english, 2011

10

Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority

Hill, Richard E.

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 393 KB

english, 2011

11

Health Canada's human vaccine lot release program: impact on the 3Rs

Isbrucker, Richard, Sontakke, Sushama, Smith, Dean

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 318 KB

english, 2011

12

European Regulatory Requirements for Veterinary Vaccine Safety and Potency Testing and Recent Progress Towards Reducing Animal Use

Woodland, Ralph

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 381 KB

english, 2011

13

Strategic Approaches for Developing Alternative Tests for Safety and Potency of Vaccines

Horiuchi, Yoshinobu, Ochiai, Masaki, Kataoka, Michiyo, Yamamoto, Akihiko, Yuen, Chun-Ting, Asokanathan, Cathy, Corbel, Michael, Kurata, Takeshi, Xing, Dorothy

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 536 KB

english, 2011

14

International regulatory requirements for vaccine safety and potency testing: a WHO perspective&

Shin, Jinho, Lei, Dianliang, Conrad, Christoph, Knezevic, Ivana, Wood, David

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 424 KB

english, 2011

15

Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use

Draayer, Hans

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 424 KB

english, 2011

16

Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency

Claassen, Ivo

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 461 KB

english, 2011

17

A case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency

Descamps, Johan, Giffroy, Didier, Remy, Eric, Mortiaux, Frederic, Mareschal, Jean-Claude, Ponsar, Cecile, Duchene, Michel

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 455 KB

english, 2011

18

Overview of Currently Approved Serological Methods with a Focus On Diphtheria and Tetanus Toxoid Potency Testing

Keller, James E.

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 627 KB

english, 2011

19

Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines

Stickings, Paul, Rigsby, Peter, Coombes, Laura, Hockley, Jason, Tierney, Rob, Sesardic, Dorothea

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 782 KB

english, 2011

20

Development and validation of serological methods for human vaccine potency testing: Case study of an anthrax vaccine

Arciniega, Juan L, Domínguez-Castillo, Rocío I

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 510 KB

english, 2011

21

Humane endpoints in vaccine potency testing

Hendriksen, Coenraad F.M.

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 443 KB

english, 2011

22

Approaches to reducing animal numbers in vaccine potency testing

Kulpa-Eddy, Jodie, Srinivas, Geetha

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 372 KB

english, 2011

23

Application of the consistency approach to reduce animal use in vaccine potency testing

Kulpa-Eddy, Jodie, Dusek, David

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 375 KB

english, 2011

24

Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives

Gifford, Glen, Agrawal, Pawan, Hutchings, Donna, Yarosh, Oksana

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 351 KB

english, 2011

25

Target alternative vaccine safety testing strategies for pertussis toxin

Arciniega, Juan L, Corvette, Laura, Hsu, Henry, Lynn, Freyja, Romani, Theresa, Dobbelaer, Roland

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 523 KB

english, 2011

26

Toward replacement of the monkey neurovirulence test in vaccine safety testing

Rubin, Steven A

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 431 KB

english, 2011

27

Human Vaccines and Their Importance to Public Health

Schuchat, Anne

Journal:

Procedia in Vaccinology

Year:

2011

Language:

english

File:

PDF, 384 KB

english, 2011

Volume 5

The International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: introduction and summary

Non-animal replacement methods for human vaccine potency testing: state of the science and future directions

Improving animal welfare and reducing animal use for human vaccine potency testing: state of the science and future directions

Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions

Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions

Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions

Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions

Veterinary Vaccines and Their Importance to Animal Health and Public Health

U.S. FDA requirements for Human Vaccine Product Safety and Potency Testing

Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority

Health Canada's human vaccine lot release program: impact on the 3Rs

European Regulatory Requirements for Veterinary Vaccine Safety and Potency Testing and Recent Progress Towards Reducing Animal Use

Strategic Approaches for Developing Alternative Tests for Safety and Potency of Vaccines

International regulatory requirements for vaccine safety and potency testing: a WHO perspective&

Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use

Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency

A case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency

Overview of Currently Approved Serological Methods with a Focus On Diphtheria and Tetanus Toxoid Potency Testing

Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines

Development and validation of serological methods for human vaccine potency testing: Case study of an anthrax vaccine

Humane endpoints in vaccine potency testing

Approaches to reducing animal numbers in vaccine potency testing

Application of the consistency approach to reduce animal use in vaccine potency testing

Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives

Target alternative vaccine safety testing strategies for pertussis toxin

Toward replacement of the monkey neurovirulence test in vaccine safety testing

Contents

Human Vaccines and Their Importance to Public Health